Effects of thymectomy on late-onset myasthenia gravis without thymoma

Clinical Neurology and Neurosurgery

Volumn 109, Issue 10, 2007, Pages 858-861

  Kawaguchi, Naoki ^a   Kuwabara, Satoshi ^a   Nemoto, Yuko ^a   Fukutake, Toshio ^a   Arimura, Kimiyoshi ^b   Osame, Mitsuhiro ^b   Hattori, Takamichi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Late onset; Myasthenia gravis; Outcome; Thymectomy; Thymoma

Indexed keywords

CHOLINESTERASE INHIBITOR; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISABILITY; FEMALE; HUMAN; MALE; MYASTHENIA GRAVIS; REMISSION; STATISTICAL SIGNIFICANCE; THYMECTOMY; THYMOMA; WEAKNESS;

AGE FACTORS; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEUROLOGIC EXAMINATION; PROGNOSIS; RETROSPECTIVE STUDIES; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 35348947403     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2007.08.006     Document Type: Article

References (10)

1. Schluep M., Willcox N., Vincent A., Dhoot G.K., and Newsom-Davis J. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann Neurol 22 (1987) 212-222
2. Ciafaloni E., and Sanders D.B. Advances in myasthenia gravis. Curr Neurol Neurosci Rep 2 (2002) 89-95
3. Kissel J.T., Franklin G.M., and and the Quality Standards Subcommittee of the American Academy of Neurology. Treatment of myasthenia gravis. A call to arms. Neurology 55 (2000) 3-4
4. Gronseth G.S., and Barohn R. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Report from the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 (2000) 7-15
5. Kawaguchi N., Kuwabara S., Nemoto Y., Fukutake T., Satomura Y., Arimura K., et al. Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000. J Neurol Sci 224 (2004) 43-47
6. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America;. Jaretzki III A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., et al. Myasthenia gravis; recommendations for clinical research standards. Neurology 55 (2000) 16-23
7. Romi F., Gilhus N.E., Varhaug J.E., Myking A., Skeie G.O., and Aarli J.A. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. Eur J Neurol 9 (2002) 55-61
8. Aarli J.A. Late-onset myasthenia gravis: a changing scene. Arch Neurol 56 (1999) 25-27
9. Romi F., Gilhus N.E., and Aarli J.A. Myasthenia gravis: disease severity and prognosis. Acta Neurol Scand Suppl 183 (2006) 24-25
10. Perlo V.P., Arnason B., and Castleman B. The thymus gland in elderly patients with myasthenia gravis. Neurology 25 (1975) 294-295